Cancer Research UK has appointed Dr James Larkin as a new Senior Clinical Advisor in clinical research. Dr Larkin’s new role aims to accelerate the progress of the charity’s clinical research portfolio. He will also support the charity in helping ensure the UK can continue to participate in clinical trials across Europe after Brexit. The role will work alongside Cancer Research UK’s three other Clinical Advisors who specialise in surgery, primary care and children’s cancer. Dr James Larkin is a consultant medical oncologist and clinical researcher at The Royal Marsden, specialising in the treatment of melanoma and kidney cancer. His research focuses on immunotherapy.